Author Correction: Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy
NPJ Breast Cancer
.
2022 Dec 28;8(1):133.
doi: 10.1038/s41523-022-00503-0.
Authors
Severine Isabelle Gharbi
#
1
,
Laura A Pelletier
#
2
,
Alfonso Espada
1
,
Jesus Gutiérrez
3
,
Sonia Maria Gutiérrez Sanfeliciano
1
,
Charles T Rauch
2
,
Maria Patricia Ganado
1
,
Carmen Baquero
1
,
Elisabet Zapatero
1
,
Aiping Zhang
2
,
Jordi Benach
2
,
Anna-Maria Russell
2
,
Leticia Cano
1
,
Sandra Gomez
1
,
Howard Broughton
1
,
Nicholas Pulliam
3
,
Carmen Maria Perez
1
,
Raquel Torres
1
,
Marjoke F Debets
3
,
Alfonso de Dios
3
,
Oscar Puig
4
,
Mark T Hilgers
2
,
Maria Jose Lallena
5
Affiliations
1
Discovery Chemistry Research & Technology, Eli Lilly and Company, Madrid, Spain.
2
Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA, USA.
3
Eli Lilly and Company, Indianapolis, IN, USA.
4
Eli Lilly and Company, New York, NY, USA.
5
Discovery Chemistry Research & Technology, Eli Lilly and Company, Madrid, Spain.
[email protected]
.
#
Contributed equally.
PMID:
36577758
PMCID:
PMC9797563
DOI:
10.1038/s41523-022-00503-0
No abstract available
Publication types
Published Erratum